跳至主要内容
临床试验/TCTR20190705002
TCTR20190705002Enrolling By Invitation未知

Comparison of the clinical efficacy of subcutaneous versus oral administration of methotrexate in patients with psoriasis vulgaris

Faculty of Medicine0 个研究点目标入组 80 人开始时间: 2019年7月5日最近更新:
适应症

试验速览

阶段
未知
状态
Enrolling By Invitation
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 0 N/A (No limit)(—)
性别
All

入选标准

  • Entry criteria require a clinical diagnosis of psoriasis vulgaris in patients who had
  • the Psoriasis Area Severity Index (PASI) score > 10 or body surface area (BSA) involvement >10% or who had PASI score <10 or BSA < 10% but did not respond to topical treatment and being at least 18 years of age

排除标准

  • Exclusion criteria include pregnant or lactating women, known hypersensitivity to methotrexate, patients with malignancy or HIV-infection or hepatitis B or C infection, tuberculosis, and abnormal liver or kidney or hematologic function. All patients will have a 12-week washout of any systemic therapies including systemic corticosteroid, methotrexate, cyclosporine, acitretin, other immunosuppressive drugs, biologics and phototherapy for psoriasis prior to receiving the study drugs

研究者

发起方
Faculty of Medicine

相似试验